Anamaria Fleig Mayer

Anamaria Fleig Mayer

Auto-generated profile, based on publicly available information

Anamaria Fleig Mayer

Núcleo de Assistência, Ensino e Pesquisa em Reabilitação Pulmonar (NuReab), Universidade do Estado de Santa Catarina (UDESC), Florianópolis, Brazil

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2016 in Chest
Verified
Journal Article
Closed access
MKMANUELA KARLOH
MANUELA KARLOH
AMAnamaria Fleig Mayer
Anamaria Fleig Mayer
RMRosemeri Maurici
Rosemeri Maurici
MPMarcia M.M. Pizzichini
Marcia M.M. Pizzichini
PJPaul W. Jones
Paul W. Jones
EPEmilio Pizzichini
Emilio Pizzichini

5 September 2017 in Respiratory Care
Verified
Journal Article
Open access
PDF file
AMAnelise B Munari
Anelise B Munari
AGAline A Gulart
Aline A Gulart
KSKaroliny dos Santos
Karoliny dos Santos
RVRaysa S Venâncio
Raysa S Venâncio
MKManuela Karloh
Manuela Karloh
AMAnamaria F Mayer
Anamaria F Mayer
BACKGROUND: In multidimensional Global Initiative for Chronic Obstructive Lung Disease (GOLD) classification, the choice of the symptom assessment instrument (modified Medical Research Council dyspnea scale [mMRC] or COPD assessment test [CAT]) can lead to a different distribution of patients in each quadrant. Considering that physical activities of daily living (PADL) is an important functional outcome in COPD, the objective of this study was to determine which symptom assessment instrument is more strongly associated with and differentiates better the PADL of patients with COPD. METHODS: The study included 115 subjects with COPD (GOLD 2–4), who were submitted to spirometry, the mMRC, the CAT, and monitoring of PADL (triaxial accelerometer). Subjects were divided into 2 groups using the cutoffs proposed by the multidimensional GOLD classification: mMRC < 2 and ≥ 2 and CAT < 10 and ≥ 10. RESULTS: Both mMRC and CAT reflected the PADL of COPD subjects. Subjects with mMRC < 2 and CAT < 10 spent less time in physical activities < 1.5 metabolic equivalents of task (METs) (mean of the difference [95% CI] = −62.9 [−94.4 to −31.4], P < .001 vs −71.0 [−116 to −25.9], P = .002) and had a higher number of steps (3,076 [1,999–4,153], P < .001 vs 2,688 [1,042–4,333], P = .002) than subjects with mMRC > 2 and CAT > 10, respectively. Physical activities ≥ 3 METs differed only between mMRC < 2 and mMRC ≥ 2 (39.2 [18.8–59.6], P < .001). Furthermore, only the mMRC was able to predict the PADL alone (time active, r 2 = 0.16; time sedentary, r 2 = 0.12; time ≥ 3 METs, r 2 = 0.12) and associated with lung function (number of steps, r 2 = 0.35; walking time, r 2 = 0.37; time < 1.5 METs, r 2 = 0.25). CONCLUSIONS: The mMRC should be adopted as the classification criterion for symptom assessment in the GOLD ABCD system when focusing on PADL.

2 April 2005 in Osteoporosis International
Verified
Journal Article
Open access
PDF file
ILImpério Lombardi
Império Lombardi
LOLeda M. Oliveira
Leda M. Oliveira
AMAnamaria F. Mayer
Anamaria F. Mayer
JJJosé R. Jardim
José R. Jardim
JNJamil Natour
Jamil Natour
Osteoporotic vertebral fractures generally result in an increased kyphotic angle, which in turn may lead to disturbances in pulmonary function. The objective of the present study was to evaluate pulmonary function and quality of life in a group of osteoporotic patients. Fifteen women with osteoporosis and thoracic vertebral fractures (group 1), 20 women with osteoporosis without vertebral fracture (group 2) and 20 control women (group 3) were submitted to spirometry using a Vitatrace-130 SL spirometer and to an SF-36 quality of life questionnaire. Women with osteoporosis and vertebral fractures showed an increased kyphotic angle (median=60°) and decreased forced vital capacity (group 1 vs. group 2, P =0.020; group 1 vs. group 3, P =0.039) and forced expiratory volume in 1 s (group 1 vs. group 2, P =0.008; group 1 vs. group 3, P =0.014) when compared with women without vertebral fractures or osteoporosis. A negative correlation was observed between thoracic kyphosis and the predicted value of expiratory forced volume in 1 s ( r =−0.713, P =0.003). No differences in the quality of life were detected between the three groups studied. We conclude that women with thoracic vertebral fractures have an increased kyphotic angle and present a decrease in lung volume.

1 July 2005 in Chest
Verified
Journal Article
Closed access
ACAlejandro Casas
Alejandro Casas
JVJordi Vilaro
Jordi Vilaro
RRRoberto Rabinovich
Roberto Rabinovich
AMAnamaria Mayer
Anamaria Mayer
JBJoan Albert Barberà
Joan Albert Barberà
JRJosep Roca
Josep Roca

1 December 2011 in Brazilian Journal of Physical Therapy
Verified
Journal Article
Open access
PDF file
KCKrislainy S. Corrêa
Krislainy S. Corrêa
MKMANUELA KARLOH
MANUELA KARLOH
LMLetícia Q. Martins
Letícia Q. Martins
KSKaroliny dos Santos
Karoliny dos Santos
AMAnamaria F. Mayer
Anamaria F. Mayer
The Glittre ADL (TGlittre) test is a specifically designed to assess functional limitation in chronic obstructive pulmonary disease (COPD) patients. However, it is not known if it can differentiate the performance of these patients from healthy subjects. To investigate whether the Glittre ADL test is able to differentiate the functional capacity of COPD patients from that of healthy subjects and to compare the cardiorespiratory response between Glittre ADL and the six-minute walk test (6MWT). The study included 10 patients with COPD (GOLD 2 to 4) and 10 healthy subjects matched by age who performed the following: spirometry pre- and post-bronchodilator, a Glittre ADL test and two 6MWT on two consecutive days. The performance of COPD (FEV1%pred= 38.1±11.8, age=64±10 years, BMI=23.7±5.2 kg/ m²) was worse than the control group on TGlittre (5.26±2.9 min, 3.3±0.3 min, p0.05). The performance of COPD patients is worse than that of healthy subjects on the Glittre ADL test, with a greater increase in dyspnea and similar heart rates.

1 October 2018 in Jornal Brasileiro de Pneumologia
Verified
Journal Article
Open access
PDF file
CRCardine Martins dos Reis
Cardine Martins dos Reis
MKMANUELA KARLOH
MANUELA KARLOH
FFFernanda Rodrigues Fonseca
Fernanda Rodrigues Fonseca
RBRoberta Rodolfo Mazzali Biscaro
Roberta Rodolfo Mazzali Biscaro
GMGiovana Zarpellon Mazo
Giovana Zarpellon Mazo
AMAnamaria Fleig Mayer
Anamaria Fleig Mayer
Objective: To develop reference equations for the Glittre Activities of Daily Living test (Glittre ADL-test) on the basis of anthropometric and demographic variables in apparently healthy individuals. A secondary objective was to determine the reliability of the equations in a sample of COPD patients. Methods: This was a cross-sectional study including 190 apparently healthy individuals (95 males; median age, 54.5 years [range, 42-65]; median FEV1 = 97% [range, 91-105.2]; and median FVC = 96% [range, 88.5-102]) recruited from the general community and 74 COPD patients (55 males; mean age, 65 ± 8 years; body mass index [BMI] = 25.9 ± 4.7 kg/m2; FEV1 = 36.1 ± 14.1%; and FVC = 62.7 ± 16.1%) recruited from a pulmonary rehabilitation center. Results: The mean time to complete the Glittre ADL-test was 2.84 ± 0.45 min. In the stepwise multiple linear regression analysis, age and height were selected as Glittre ADL-test performance predictors, explaining 32.1% (p < 0.01) of the total variance. Equation 1 was as follows: Glittre ADL-testpredicted = 3.049 + (0.015 × ageyears) + (−0.006 × heightcm). Equation 2 included age and BMI and explained 32.3% of the variance in the test, the equation being as follows: Glittre ADL-testpredicted = 1.558 + (0.018 × BMI) + (0.016 × ageyears). Conclusions: The reference equations for the time to complete the Glittre ADL-test were based on age, BMI, and height as independent variables and can be useful for predicting the performance of adult individuals. The predicted values appear to be reliable when applied to COPD patients.